Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
36.22 Up 0.50(1.40%) Mar 27, 4:00PM EDT
Add to Portfolio
Prev Close:35.72
Open:35.71
Bid:31.00 x 100
Ask:36.49 x 500
1y Target Est:42.70
Beta:2.4
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:35.47 - 36.44
52wk Range:30.05 - 47.67
Volume:827,808
Avg Vol (3m):1,210,910
Market Cap:4.50B
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENUp 1.40%4.50B
IMGNUp 3.38%710.38M
PFEUp 1.08%211.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.71
Quarterly EPS Est (Mar-15) :-0.19
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-2.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback